Renoud Marijnissen

Renoud Marijnissen is an accomplished professional with extensive experience in research and development within the biotechnology sector. Currently serving as Director of R&D Strategic Initiatives and Team Lead for Research & Innovation at Genmab since May 2017, Renoud Marijnissen focuses on the discovery and development of proprietary antibody technology platforms. Prior roles include Director and Associate Director of Research Program Management at Genmab, and Project Manager and Study Director for Immunology at Triskelion B.V. Additionally, Renoud Marijnissen has a strong academic foundation, with a PhD from Radboud University Nijmegen Medical Centre, where research concentrated on Th17 cells in synovial environments, and a postdoctoral position at UMC Utrecht studying dendritic cells and T-cell profiles in rheumatic diseases. Renoud Marijnissen also contributed to the UMC-council, advising on education and research matters.